Baxter International Faces Fresh Product Recall of Sodium Chloride IV Bags Over Fiberglass Contamination

Baxter International Inc. (NYSE: BAX) has issued a voluntary, nationwide recall of two lots of its 0.9% sodium chloride injection bags distributed across the U.S., after discovering potential fiberglass particulate contamination. This development was confirmed via a report referencing FDA disclosure.

The recall was disclosed this month and pertains to two specific lots of intravenous saline solutions. The recall communication indicates customers will receive guidance on how to identify and return the impacted products. The FDA has been officially notified of the action. While the recall spans multiple states, the specific lot numbers and distribution details were not specified in the available summary. Healthcare providers and facilities impacted are advised to follow Baxter’s instructions for handling and returning the affected inventory.

No reports of adverse health outcomes have been made public in relation to this recall to date.

Sources: Fierce Pharma information on Baxter’s voluntary recall of antibiotic IV bags; FDA notifications as reported via Reddit community highlighting additional fiberglass-related recalls over the past week.